Application
Fig1: Western blot analysis of CSNK2B on human CSNK2B recombinant protein using anti-CSNK2B antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of CSNK2B on HEK293 (1) and CSNK2B-hIgGFc transfected HEK293 (2) cell lysate using anti-CSNK2B antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of CSNK2B on different cell lysates using anti-CSNK2B antibody at 1/1,000 dilution. Positive control: Line1: Hela Line2: Jurkat Line3: K562 Line4: HepG2 Line5: C6 Line6: SK-N-SH Line7: NTERA-2 Line8: MCF-7 Line9: NIH/3T3
Application
Fig4: ICC staining CSNK2B (green) and Actin filaments (red) in MCF-7 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-CSNK2B antibody. Counter stained with hematoxylin.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human colon?cancer tissue using anti-CSNK2B antibody. Counter stained with hematoxylin.
Application
Fig7: Flow cytometric analysis of Hela cells with CSNK2B antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).